These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35577490)

  • 1. Correlation between brain glucose metabolism (
    Albano D; Premi E; Peli A; Camoni L; Bertagna F; Turrone R; Borroni B; Calhoun VD; Rodella C; Magoni M; Padovani A; Giubbini R; Paghera B
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(3):146-152. PubMed ID: 35577490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning model for generating [
    Sanaat A; Boccalini C; Mathoux G; Perani D; Frisoni GB; Haller S; Montandon ML; Rodriguez C; Giannakopoulos P; Garibotto V; Zaidi H
    Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3518-3531. PubMed ID: 38861183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracer-specific reference tissues selection improves detection of
    Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y;
    Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
    Bailly M; Ribeiro MJ; Vercouillie J; Hommet C; Gissot V; Camus V; Guilloteau D
    Clin Nucl Med; 2015 Feb; 40(2):e111-6. PubMed ID: 25549345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-phase
    Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.
    Newberg AB; Arnold SE; Wintering N; Rovner BW; Alavi A
    J Nucl Med; 2012 Jun; 53(6):902-7. PubMed ID: 22577238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.
    Hsiao IT; Huang CC; Hsieh CJ; Hsu WC; Wey SP; Yen TC; Kung MP; Lin KJ
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):613-20. PubMed ID: 22270508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score.
    Zukotynski K; Gaudet V; Kuo PH; Adamo S; Goubran M; Scott CJM; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce R; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE
    Clin Nucl Med; 2020 Jun; 45(6):427-433. PubMed ID: 32366785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-phase [18F]florbetapir in frontotemporal dementia.
    Asghar M; Hinz R; Herholz K; Carter SF
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):304-311. PubMed ID: 30569187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.
    Camus V; Payoux P; Barré L; Desgranges B; Voisin T; Tauber C; La Joie R; Tafani M; Hommet C; Chételat G; Mondon K; de La Sayette V; Cottier JP; Beaufils E; Ribeiro MJ; Gissot V; Vierron E; Vercouillie J; Vellas B; Eustache F; Guilloteau D
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):621-31. PubMed ID: 22252372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
    Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
    J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Correlation of Static First-Minute-Frame (FMF) PET Imaging after
    Seiffert AP; Gómez-Grande A; Villarejo-Galende A; González-Sánchez M; Bueno H; Gómez EJ; Sánchez-González P
    Sensors (Basel); 2021 Jul; 21(15):. PubMed ID: 34372416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
    Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
    J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of amyloid PET using
    Matsuda H; Okita K; Motoi Y; Mizuno T; Ikeda M; Sanjo N; Murakami K; Kambe T; Takayama T; Yamada K; Suehiro T; Matsunaga K; Yokota T; Tateishi U; Shigemoto Y; Kimura Y; Chiba E; Kawashima T; Tomo Y; Tachimori H; Kimura Y; Sato N
    Ann Nucl Med; 2022 Dec; 36(12):1039-1049. PubMed ID: 36194355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Takahashi R; Ishii K; Yokoyama K; For The Alzheimer S Disease Neuroimaging Initiative EY
    Curr Alzheimer Res; 2017; 14(2):161-168. PubMed ID: 27334941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.